Latest Breaking News On - Exelixis inc - Page 3 : comparemela.com

Weiss Asset Management LP Invests $320,000 in Exelixis, Inc (NASDAQ:EXEL)

Weiss Asset Management LP Invests $320,000 in Exelixis, Inc (NASDAQ:EXEL)
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

United statesGeorge posteAlanm garberCharles schwab investment management incExelixis incExchange commissionCapital managementNorges bankRoyal bankAmeriprise financial incWeiss asset managementFree reportSchwab investment managementGet free reportDirector alanDirector george poste

Exelixis to Present at the William Blair 44th Annual Growth Stock Conference

Exelixis, Inc. today announced that company management will participate in a fireside chat at the William Blair 44th Annual Growth Stock Conference on Tuesday, June 4 at 4:20 p.m. ET / 3:20 p.m. CT / 1:20 p.m. PT in Chicago. To access the webcast.

United statesWilliam blairExelixis incTrade showAnnual growth stockAnnual growth stock conferenceEvent calendar

Exelixis to Present at the William Blair 44th Annual Growth Stock Conference

Exelixis to Present at the William Blair 44th Annual Growth Stock Conference
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesWilliam blairExelixis incAnnual growth stock conferenceEvent calendar

Exelixis Announces Settlement of CABOMETYX® (cabozantinib) Patent Litigation with Cipla Limited and Cipla USA

Exelixis, Inc. today announced that it has entered into a Settlement and License Agreement with Cipla Ltd. and Cipla USA, Inc. . This settlement resolves two patent litigations brought by Exelixis.

United statesDrug administrationUs district courtExchange commissionUs department of justiceCipla united states incCipla ltdUs federal trade commissionExelixis incLicense agreementCipla united statesAbbreviated new drug applicationCivil actionTrade commissionAnnual reportQuarterly reports

Exelixis Announces Settlement of CABOMETYX (cabozantinib) Patent Litigation with Cipla Limited and Cipla USA

20.05.2024 - Exelixis, Inc. (Nasdaq: EXEL) today announced that it has entered into a Settlement and License Agreement (Agreement) with Cipla Ltd. and Cipla USA, Inc. (collectively Cipla). This settlement resolves two patent litigations brought by Exelixis in .

United statesExelixis incUs district courtExchange commissionUs department of justiceUs federal trade commissionTrade commissionAnnual reportQuarterly reports